Cargando…
(756) Immunogenicity of COVID-19 Vaccination in Cardiac Transplant Recipients: 5 Months Follow-Up after the 3rd Dose
PURPOSE: Vaccination against COVID 19 has been shown to improve outcomes after transplant. There are prior reports of vaccines leading to sensitization in transplant recipients, however, little is known about the development of de novo (dn) anti-HLA antibodies (abs) after COVID-19 vaccination (COVAX...
Autores principales: | Rahman, A., Golombeck, D., Malhame, K., Rossi, D., Wallach, F., Avila, M., Maybaum, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068032/ http://dx.doi.org/10.1016/j.healun.2023.02.770 |
Ejemplares similares
-
Letter to the Editor: Immunogenicity After the Third Dose of COVID-19 Vaccine in Cardiac Transplantation
por: Rahman, Afsana, et al.
Publicado: (2023) -
Development of De Novo Donor Specific Antibodies Following COVID-19 Vaccination in Cardiac Transplant
por: Maybaum, S., et al.
Publicado: (2022) -
Biopsy-Proven Renal-Limited Thrombotic Microangiopathy in a Heart Transplant Recipient
por: Bharati, Joyita, et al.
Publicado: (2023) -
Direct and heterologous approaches to identify the LET-756/FGF interactome
por: Popovici, Cornel, et al.
Publicado: (2006) -
Etiological distribution of pertussis-like syndrome in 756 children in Chengdu
por: Liu, Yanru, et al.
Publicado: (2021)